Bactiguard and Svenskt Industriflyg establish air bridge for protective medical equipment
The rapid spread of the virus pandemic has led to a large number of countries closing their borders and transport capacity disappearing, as airlines discontinue routes and cancel departures. The effects on the global economy and trade are significant and will lead to uncertain supply of goods and difficulties in increasing delivery capacity for manufacturing companies. This affects the healthcare system which has an urgent need for protective medical equipment. Therefore, Bactiguard and Svenskt Industriflyg will establish an air bridge between Asia and Europe, which will also be available to other Swedish companies.
“The rapid spread of the pandemic is a major challenge for the healthcare sector, companies and the world economy. At the same time, there are many companies and individuals who want to contribute by providing solutions that improve the availability of the products most urgently needed,” says Cecilia Edström, CEO of Bactiguard.
“Bactiguard will use the air bridge to transport products for infection prevention, including the recently launched Hydrocyn aqua, from our facilities in Malaysia to Sweden at a rate that wouldn’t otherwise be possible. At the same time, we want to open up the opportunity for other companies with similar challenges to join this initiative,” Cecilia Edström continues.
“As the regular alternatives become more and more limited, we are happy to be able to provide transport capacity. My fellow employees at Svenskt Industriflyg specialize in complex transport solutions and we are grateful for the opportunity of contributing to the effort of providing Swedish healthcare with vital equipment,” says Brian Liddle, CEO of Svenskt Industriflyg.
For further information, please contact:
Cecilia Edström, CEO, phone +46 8 440 58 80
Brian Liddle, CEO Svenskt Industriflyg, phone +46 8 564 850 90
About Svenskt Industriflyg AB (Industriflyg)
Industriflyg stands alone in being able to supply its customers with turnkey solutions, from security assessments through its sister company Scutus through safeguarding during travels, medical support in the air and on the ground in partnership with Medaire & Karolinska University Hospital, as well as transportation at the highest level of safety and efficiency in some of the worlds most advanced aircraft.
Industriflyg’s aircraft are not only used for executive and personal travel, but also for special missions and complex transportation needs that are difficult or impossible to solve with traditional travel solutions.
Industriflyg has a dedicated team of 85 professionals accustomed to performing in a demanding environment. Operating 10 aircraft, ranging from light jets to ultra-long haul, and two helicopters. Stockholm City Bromma Airport is the main base of operations, which also includes our own FBO which supports both our own operations as well as charter operators the world over.
About Bactiguard
Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission, we develop and supply infection prevention solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large.
The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner BD, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.
Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. Recently, Bactiguard completed the acquisition of Malaysian Vigilenz, a manufacturer and supplier of medical devices and consumables, primarily within wound care and infection prevention.
Following the acquisition, Bactiguard has about 180 employees around the world. Its headquarters and one of three production facilities are located in Stockholm, the other two in Malaysia.
Bactiguard is listed on Nasdaq Stockholm.
Read more about how Bactiguard saves lives at www.bactiguard.com
Tags: